Related Experiment Video
Updated: May 23, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.
Anand B Pithadia1, Sunita M Jain
1Department of pharmacology, L.M. College of Pharmacy, Navrangpura, Ahmedabad-3800 09, India.
Journal of Clinical Medicine Research
|April 17, 2012
Summary
5-hydroxytryptamine (5-HT) is a complex biogenic amine with diverse receptor subtypes. Modulators targeting these 5-HT receptors show therapeutic potential for conditions like migraine, anxiety, and psychosis.
Area of Science:
- Neuroscience and Pharmacology
- Biochemistry
Background:
- 5-hydroxytryptamine (5-HT), a key biogenic amine, interacts with numerous receptor subtypes.
- Identification of 5-HT receptor subtypes (5-HT1-7) is crucial for understanding its complex roles.
- The development of selective 5-HT receptor modulators is an active area of pharmaceutical research.
Purpose of the Study:
- To review the discovery, biosynthesis, metabolism, and physiological functions of 5-HT.
- To explore the therapeutic potential of 5-HT receptor modulators across various disease states.
- To highlight the established efficacy of 5-HT receptor modulators in specific conditions.
Main Methods:
- Literature review of 5-HT research, including receptor identification and drug development.
- Analysis of the physiological roles of 5-HT in nervous, cardiovascular, and gastrointestinal systems.
- Examination of clinical applications and therapeutic advantages of 5-HT receptor modulators.
Main Results:
- Detailed characterization of identified 5-HT receptor subtypes (e.g., 5-HT1A-F, 5-HT2A-C, 5-HT3, 5-HT4, 5-HT5A-B, 5-HT6, 5-HT7).
- Demonstration of therapeutic efficacy for 5-HT receptor modulators in treating migraine, anxiety, psychosis, obesity, and chemotherapy-induced emesis.
- Discussion of potential applications in nervous system disorders, cardiovascular conditions, GI tract disorders, bone growth, and micturition.
Conclusions:
- 5-HT receptor modulators offer significant therapeutic potential for a wide range of conditions.
- Targeting specific 5-HT receptor subtypes represents a promising strategy in drug development.
- Further research into 5-HT's multifaceted roles may uncover novel therapeutic avenues.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...